Completed NA INTERVENTIONAL 2-arm NCT02122198

Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

Sponsor: University of Colorado, Denver

Conditions Cardiovascular Disease Cognitive Impairment Endothelial Dysfunction Executive Dysfunction

Interventions Estradiol Leuprolide acetate Medroxyprogesterone Placebo

Updated 9 times since 2017 Last updated: Dec 10, 2021 Started: Sep 8, 2014 Primary completion: May 30, 2017 Completion: Sep 15, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cardiovascular Disease and Cognitive Impairment, this trial is completed. The trial is conducted by University of Colorado, Denver and has accumulated 9 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Feb 2022 [monthly]

Completed NA
Aug 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 4 earlier versions

Jun 2018 — Aug 2018 [monthly]

Completed NA
Dec 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2017 — Dec 2017 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Colorado, Denver

Data source: University of Colorado, Denver

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aurora, United States
• Boulder, United States